Eris Lifesciences Ltd (NSE:ERIS)
₹ 1042.9 11.1 (1.08%) Market Cap: 141.66 Bil Enterprise Value: 155.44 Bil PE Ratio: 36.17 PB Ratio: 5.48 GF Score: 97/100

Q4 2019 Eris Lifesciences Ltd Earnings Call Transcript

May 21, 2019 / 11:30AM GMT
Release Date Price: ₹605.6 (-1.37%)
Operator

Ladies and gentlemen, good day, and welcome to the Eris Lifesciences Q4 FY '19 Results Conference Call, hosted by Axis Capital Limited. (Operator Instructions) Please note this conference is being recorded.

I now hand the conference over to Mr. Prakash Agarwal of Axis Capital Limited. Thank you, and over to you, Mr. Agarwal.

Prakash Agarwal
Axis Capital Limited, Research Division - Executive Director of Pharmaceuticals

Yes, thanks. I welcome you all on behalf of Axis Capital to the Q4 Fiscal '19 Eris Lifesciences Con Call, represented by the senior management. Over to you, sir.

Amit Indubhushan Bakshi
Eris Lifesciences Limited - Chairman & MD

Thank you, Prakash. Good evening, everybody. Since this is the year-ending call, I would request some time for you -- for me to take you over through a couple of slides. It -- these are the same slides, which we have put into the presentation as the presentation for quarter 4 and FY '19.

So I'm just following our slides, giving you a broad indication of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot